Skip to content

Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers

Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers: a Retrospective Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03121183
Acronym
GAINE LASER
Enrollment
45
Registered
2017-04-20
Start date
2015-03-31
Completion date
2018-06-30
Last updated
2017-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Equipment Failure, Heart Failure, Prosthesis-Related Infections, Thrombosis

Keywords

Cardiology, Device Removal, Pacemaker, Defibrillators, Catheterization, Laser Therapy, Cost-Benefit Analysis

Brief summary

The growing use and the expanding indications for cardiovascular implantable electronic devices (CIEDs) have been associated to an increase of device removal. The indications of CIEDs removal are infectious (55%) or noninfectious (45%) such as upgrading of devices, nonfunctional devices and thrombosis. Removal can be performed according to transvenous or surgical procedures. Transvenous lead removal (TLR) must be done by experimented cardiologists and respecting current consensus. TLR can be done with conventional techniques involving inserting locking stylets and telescoping sheaths around the pacing leads to separate them from the surrounding scar tissue. These conventional procedures have a success rate of ≈65%. TLR thanks to laser sheath has been validated and improved the success rate until \>95%. However, the TLR from chronically implanted CIEDs still carries a significant risk of procedural failure, morbidity, and mortality, related to tearing of the great vessels and cardiac structures, even when performed by experienced operators. Even if the transvenous extraction using laser sheath seems to be more effective, this strategy would be more expensive. Considering the availability of several strategies for TLR and the cost heterogeneity of procedures, a cost assessment in real life of these therapeutic strategies is essential for an optimal choice of therapeutic strategies.

Detailed description

The study will compare the strategies of percutaneous extraction to surgical extraction. * Mechanical percutaneous extraction is the conventional technique using locking stylets and telescoping sheaths around the pacing leads to separate them from the surrounding scar tissue. * Laser-assisted lead extraction is most often used in complex procedures and dissolves rather than tear the scar tissue. * Sternotomy is the surgical procedure used when leads cannot be removed by percutaneous extraction. It is rarely employed.

Interventions

DEVICELaser sheath

Patients who have undergone an extraction of implantable pacemaker or defibrillator leads whatever the indication for the period march 2015-2017

BEHAVIORALImplantable Cardiac Device lead extraction

Patients who have undergone an extraction of implantable pacemaker or defibrillator leads whatever the indication for the period march 2015-2017

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \- Patients who have undergone an extraction of implantable pacemaker or defibrillator leads whatever the indication for the period march 2013-2017

Exclusion criteria

* \- None

Design outcomes

Primary

MeasureTime frameDescription
Direct medical costat day 1Overall cost of care according to the hospital perspective: drug treatment, medical device, catheterization lab occupancy, operating room occupancy, medical and nursing staff time, hospitalization

Secondary

MeasureTime frameDescription
Type of interventionat day 1mechanical percutaneous extraction, laser percutaneous extraction, surgical extraction
Indication of the interventionat day 1infectious, technical failure or other
Extracted leads characteristicsat day 1number, type, age, failure
Patient characteristicsat day 1age, sex, origin (general hospital, university hospital, other)
Number and type of complicationsat day 1tamponade, vascular rupture, haemothorax, equipment breakage, death…
Investment cost for the hospital and dampingat day 1annual projections: medical device and supplies
Duration of hospitalizationat day 1pre and post-extraction
Duration of extraction procedure and fluoroscopyat day 1for percutaneous extraction
quotation ranking of each patient for revenue valuationat day 1quotation ranking of each patient for revenue valuation
Number of rehospitalizationat day 1duration, cause and service
percutaneous extractionat day 1number of surgical transformation (sternotomy)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026